Retatrutide 20mg Vial

Retatrutide 20mg Vial is a research-grade lyophilized peptide formulation supplied in sterile vial form for laboratory and investigational use only. It contains Retatrutide, a triple receptor agonist that acts on GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors, which are key pathways involved in metabolic regulation, glucose homeostasis, and energy balance.

This compound is being studied in clinical research for its potential role in obesity and metabolic disorder models, where simultaneous activation of these three receptors has been associated with effects on appetite regulation, insulin secretion, and energy expenditure in experimental settings.

Each vial contains 20mg of Retatrutide in a freeze-dried (lyophilized) powder form, designed for stability and reconstitution in controlled laboratory environments. The peptide is not intended for direct human consumption outside of approved clinical trials.